reproduce it,” said Cohen. She’s an instructor at the University of Pennsylvania’s Perelman School of Medicine who credited the study authors for being forthcoming about their limitations. “We definitely need to take from it what we can.”
While suPAR’s link to kidney disease has been explored for years, the marker generally remains a mystery for scientists, said Cohen, who described suPAR as “a unique biomarker” that holds promise in helping to discriminate which people are at higher risk for death. But suPAR also represents “a very broad umbrella because it could be associated with so many things.”
“We really still don’t understand suPAR,” she said. “We really don’t know what it does, and we don’t know why it causes adverse outcomes. Studies like this are helpful in giving us more clues.”
Although no one may want to truly know their fate with a single test, it may be helpful in coming to terms with the time you have left. It may also help ease your mind to know how severe your condition may be. You may find yourself with enough time to get on track and reverse your diabetes through healthy eating and exercise.
For more information on diabetes on BlackDoctor.org, visit here.
SOURCES:
Journal of the American Heart Association, Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein, May 1, 2018